Molecure S.A.
MOC.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 3 | PLN 0 | PLN 0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | PLN 0 | PLN 0 | PLN 1 | PLN 1 |
| Gross Profit | PLN 0 | PLN 3 | -PLN 1 | -PLN 1 |
| % Margin | – | 89.3% | – | – |
| R&D Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 1 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| SG&A Expenses | PLN 4 | PLN 6 | PLN 0 | PLN 10 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | -PLN 0 | PLN 1 | PLN 5 | -PLN 2 |
| Operating Expenses | PLN 5 | PLN 6 | PLN 5 | PLN 10 |
| Operating Income | -PLN 5 | -PLN 4 | -PLN 6 | -PLN 11 |
| % Margin | – | -125% | – | – |
| Other Income/Exp. Net | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Pre-Tax Income | -PLN 5 | -PLN 4 | -PLN 5 | -PLN 10 |
| Tax Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Net Income | -PLN 5 | -PLN 4 | -PLN 5 | -PLN 10 |
| % Margin | – | -116.8% | – | – |
| EPS | -0.26 | -0.17 | -0.26 | -0.52 |
| % Growth | -52.9% | 34.6% | 50% | – |
| EPS Diluted | -0.26 | -0.17 | -0.26 | -0.52 |
| Weighted Avg Shares Out | 21 | 21 | 20 | 20 |
| Weighted Avg Shares Out Dil | 21 | 21 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Interest Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Depreciation & Amortization | PLN 1 | PLN 1 | PLN 1 | PLN 1 |
| EBITDA | -PLN 5 | -PLN 2 | -PLN 4 | -PLN 10 |
| % Margin | – | -80% | – | – |